Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

Group 1 - Longi Green Energy has decided to terminate its plan for issuing global depositary receipts overseas and listing on the Swiss Stock Exchange, citing stable production and operations as reasons for this cautious decision [1] - Borui Communication plans to acquire a 51% stake in Meijing Technology for 66.49 million yuan to enhance its focus on modern media and digital transformation [2] - Tianyuan Dike's chairman has been placed under detention by the local supervisory authority, but the company assures that its operations remain normal and unaffected [3] Group 2 - Rhine Biotech is planning a change in control and asset acquisition, leading to a suspension of its stock trading starting December 10 [4] - Fosun Pharma's subsidiary has signed a licensing agreement with Pfizer, which includes an upfront payment of 15 million USD and potential milestone payments up to 35 million USD for the development of a GLP-1R agonist [5] - Yongmaotai intends to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy components [6] Group 3 - Huayi Group's subsidiary has been ordered to suspend operations for environmental remediation, which is expected to impact production [7][8] - Boyuan Chemical's subsidiary has commenced trial production of a 1 million tons/year soda ash production line, enhancing its market position [9] - Tiandi Technology plans to invest 3.545 billion yuan in a research center for intelligent mining equipment in Xi'an [10] Group 4 - Daye Co. has a minor stake in Jiangbei Company, which focuses on aerospace products, but its financial impact is limited due to the small shareholding [11] - Xiamen Airport is planning to acquire 100% of its controlling shareholder's subsidiary to adapt to the upcoming changes in airport operations [12] - Zhaoyi Innovation has received approval from the CSRC for its overseas listing of H-shares, planning to issue up to 51.8 million shares [13] Group 5 - Yangfan New Materials' controlling shareholder has been released from detention, allowing normal operations to resume [14] - Tangrenshen reported a decline in pig sales revenue for November, with a 24.05% decrease month-on-month [15][16] - China Merchants Shekou achieved a sales amount of 14.094 billion yuan in November, with cumulative sales reaching 170.166 billion yuan for the year [17] Group 6 - Zhengbang Technology reported a slight increase in pig sales revenue for November, with a 8.55% rise month-on-month [18] - Luoniushan's pig sales revenue increased by 13.57% year-on-year in November, despite a slight decline in monthly sales [19] - Tiankang Bio reported a 1.2% increase in pig sales revenue for November, with a year-to-date decline in total revenue [20] Group 7 - Huitai Medical plans to repurchase shares worth 200 million to 250 million yuan for employee stock ownership plans [21] - Financial Street's major shareholder increased its stake by 703,840 shares, raising its ownership to nearly 15% [22] - Shenzhou Information's major shareholder plans to reduce its stake by up to 3% [23] Group 8 - Yingpais plans to increase its stake in the company by 60 million to 120 million yuan within six months [24] - Jingu Co. intends to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [25] - Songcheng Performing Arts plans to repurchase shares worth 100 million to 200 million yuan for capital reduction [26] Group 9 - Bai'ao Intelligent has pre-won contracts for projects totaling 27.5 million yuan, which is expected to positively impact future performance [27] - Heshun Electric has been awarded a procurement project from the State Grid worth 107 million yuan, representing nearly 25% of its projected revenue [28] - Jinggong Technology signed a sales contract worth 729 million yuan, accounting for 42.16% of its expected annual revenue [29] Group 10 - Zhongchao Holdings' subsidiary received an order for high-temperature alloy precision castings worth 51.56 million yuan [30] - Wanma Technology has pre-won multiple projects from the State Grid totaling 59.94 million yuan [31] - ST Weihai, in partnership with a construction institute, won a contract for a smart agriculture project worth 652 million yuan [32] - Chongqing Construction's subsidiary has secured a construction project worth 1.714 billion yuan [33]

12月9日晚间，重庆建工（600939）发布公告称，全资子公司重庆交通建设(集团)有限责任公司(简称"交 建集团")和重庆建工市政交通工程有限责任公司(简称"市政交通公司")组建的联合体，参与八横线白市 驿隧道至黄桷坪长江大桥段工程施工二标段项目投标。近日，联合体已收到中标通知书，确认其中标该 项目。 根据《共同投标协议》等相关约定，交建集团作为联合体牵头人，代表所有联合体成员负责本项目投标 及施工合同实施阶段的主办协调工作，全面履行招标文件中联合体牵头人的相关职责。市政交通公司作 为联合体成员单位，与联合体牵头人共同承担招标范围内的施工任务。联合体各方均为公司合并报表范 围内的全资子公司，其各自承担施工任务待后续另行划分。(郑渝川) 公告显示，项目位于重庆市大渡口区、九龙坡区。主线为双向6车道，设计车速80km/h，道路等级为城 市快速路，主要包括1处主线隧道，1处接线隧道，2座主线桥梁等工程。中标价约为17.14亿元，项目工 期为2160天。 ...

资料显示，重庆建工为2025年《财富》中国排行榜500强企业，历经70余年深耕积淀，始终聚焦品牌建 设与企业形象塑造，在建筑施工领域积累了深厚经验，构建起较为完善的内部质量管控体系，并形成一 定的区域性竞争优势与品牌影响力，赢得业主群体的高度认可。凭借较强的综合实力，公司业务布局已 覆盖全国各省、市、自治区，并拓展至全球20多个国家和地区，承建了众多标杆工程，在行业内树立了 较强的竞争优势。 中证智能财讯重庆建工（600939）12月9日晚间公告，公司全资子公司重庆交通建设（集团）有限责任 公司与重庆建工市政交通工程有限责任公司组建的联合体，近日收到八横线白市驿隧道至黄桷坪长江大 桥段工程施工二标段项目中标通知书，项目中标价为17.14亿元。 据公告，上述项目位于重庆市大渡口区、九龙坡区，主线为双向6车道城市快速路，设计车速80公里/小 时，主要建设内容包括1处主线隧道、1处接线隧道及2座主线桥梁等工程，项目工期为2160日历天。 根据联合体约定，交建集团作为牵头人，负责项目投标及施工合同实施阶段的主办协调工作，全面履行 牵头人相关职责；市政交通公司作为成员单位，与牵头人共同承担招标范围内的施工任务。联合体各 ...

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

重庆建工（600939）(600939.SH)发布公告，公司之全资子公司重庆交通建设(集团)有限责任公司(以下 简称"交建集团")和重庆建工市政交通工程有限责任公司(以下简称"市政交通公司")组建的联合体，参与 八横线白市驿隧道至黄桷坪长江大桥段工程施工二标段项目投标。近日，联合体已收到中标通知书，确 认其中标该项目。此次中标价17.14亿元。 ...

智通财经APP讯，重庆建工(600939.SH)发布公告，公司之全资子公司重庆交通建设(集团)有限责任公司 (以下简称"交建集团")和重庆建工市政交通工程有限责任公司(以下简称"市政交通公司")组建的联合 体，参与八横线白市驿隧道至黄桷坪长江大桥段工程施工二标段项目投标。近日，联合体已收到中标通 知书，确认其中标该项目。此次中标价17.14亿元。 ...

| 转债代码：110064 | 转债简称：建工转债 | | | | --- | --- | --- | --- | | 证券代码：600939 债券代码：254104 | 证券简称：重庆建工 渝建 债券简称：24 | 01 | 公告编号：临 2025-121 | 重庆建工集团股份有限公司 关于工程项目中标的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、本项目基本概况 项目名称：八横线白市驿隧道至黄桷坪长江大桥段工程施工二标 段 中标价：1,713,980,327.03 元 三、风险提示 — 1 — 重庆建工集团股份有限公司（以下简称"公司"）之全资子公司重 庆交通建设（集团）有限责任公司（以下简称"交建集团"）和重庆 建工市政交通工程有限责任公司（以下简称"市政交通公司"）组建 的联合体，参与八横线白市驿隧道至黄桷坪长江大桥段工程施工二标 段项目投标。近日，联合体已收到中标通知书，确认其中标该项目。 项目概况：项目位于重庆市大渡口区、九龙坡区。主线为双向 6 车道，设计车速 80kmh，道路等级为城市快速路， ...

中标通知书 2、交通工程(不含预留预埋、含抗滑薄层)纳入专业工程暂估价。 3、绿化工程(包含景观植物、生态袋、三维网喷播植草、挂网植草、种植土回填(不含 生物滞留带及洞顶种植士回填）等)纳入专业工程暂估价。 工程规模:项目起于内环快速路华岩立交东侧,向东分别穿越双山、九宫庙、重钢、黄摘 坪等片区后,止于黄梅坪立交西侧。道路全长 8.388km,主线为双向 6 车道,设计车速 80km/h, 道路等级为城市快速路,主要包括九宫庙隧道(标准净宽13.5m、净高 5m、左线隧道长 3556.75m、 右线隧道长 3517.88m),黄棉坪隧道(标准净宽13.5m、净高 5m、左线隧道长 2915.271m、右 线隧道长 2856. 227m),2 处接线隧道(双山连接隧道、锦龙路接线隧道),1 座互通立交(重 钢立交）及钢花路连接线,不包含铁路交叉共建段(左线 ZK6+923~ZK7+127、右线 YK6+858~ YK7+061)。 中标工期为:2160 日历天。 缺陷责任期要求:24个月。 中标人:重庆交通建设(集团)有限责任公司(联合体牵头单位) 重庆建工市政交通工程有限责任公司(联合体成员单位) 我单位拟建 ...

人民财讯12月9日电，重庆建工（600939）12月9日公告，公司全资子公司重庆交通建设(集团)有限责任 公司和重庆建工市政交通工程有限责任公司组建的联合体，参与了八横线白市驿隧道至黄桷坪长江大桥 段工程施工二标段项目投标。近日，联合体已收到中标通知书，确认其中标该项目，中标价为17.14亿 元，项目工期为2160天。 ...